Showing results (151-160 of 210) with videos related to
Sort By:
Pageof 21
American Journal of Disaster Medicine|June 18, 2011
Regional public health preparedness teams in North Carolina: an analysis of their structural capacity and impact on services providedJennifer A Horney, Milissa Markiewicz, Anne Marie Meyer, et al.The British Journal of Dermatology|March 1, 1995
p53 immunoreactivity is uncommon in primary cutaneous lymphomaJ M McGregor, E A Dublin, D A Levison, et al.Journal of the American Academy of Dermatology|August 1, 1990
Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063A C Markey, J N Barker, C B Archer, et al.American Journal of Public Health|October 19, 2013
We can have it all: improved surveillance outcomes and decreased personnel costs associated with electronic reportable disease surveillance, North Carolina, 2010Erika Samoff, Lauren Dibiase, Mary T Fangman, et al.The American Journal of Pathology|October 1, 1993
Expression of selectin ligands by cutaneous squamous cell carcinomaR W Groves, M H Allen, E L Ross, et al.The Journal of Investigative Dermatology|March 1, 1992
Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skinR W Groves, E Ross, J N Barker, et al.Sexually Transmitted Diseases|December 21, 2011
Developing a predictive model to prioritize human immunodeficiency virus partner notification in North CarolinaBrooke E Hoots, Pia D M MacDonald, Lisa B Hightow-Weidman, et al.Public Health Reports (Washington, D.C. : 1974)|November 11, 2020
Gaps in Knowledge About COVID-19 Among US Residents Early in the OutbreakLauren A McCormack, Linda Squiers, Alicia M Frasier, et al.Immunology|February 1, 1994
Langerhans' cell expression of the selectin ligand, sialyl Lewis xE L Ross, J N Barker, M H Allen, et al.The American Journal of Pathology|April 1, 1993
Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-gammaJ N Barker, J R Goodlad, E L Ross, et al.Pageof 21